NCT04489290View on ClinicalTrials.gov

Efficacy and Safety of D005 Vaginal Mousse on Bacterial Vaginosis

NAActive, not recruitingINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

February 12, 2021

Primary Completion Date

October 4, 2023

Study Completion Date

February 28, 2024

Conditions
Bacterial Vaginosis | Vaginal | Microbiology
Interventions
DEVICE

D005 Vaginal Mousse

D005 Vaginal Mousse is class IIa medical device for treatment of Bacterial Vaginosis.

OTHER

Placebo

Placebo

Trial Locations (9)

Unknown

Ladulaas Kliniska Studier, Borås

Hoftekliniken,, Helsingborg

Qvinnolivet Praktikertjänst AB, Kungsbacka

Hälsomedicinskt Center Barnmorskemottagning, Lomma

2Heal Medical, Stockholm

Kvinnokliniken, Danderyds Sjukhus, Stockholm

Ondrasek Läkarmottagning, Sundsvall

Gynekologisk mottagning Centrum för Obstetrik och gynekologi Norrlands Universitetssjukhus, Umeå

G20 0XA

CPS Research, Glasgow

Sponsors

Collaborators (1)

CPS Research
All Listed Sponsors
collaborator

Key2Compliance

INDUSTRY

collaborator

CPS Research

UNKNOWN

collaborator

Scandinavian Development Services AB

UNKNOWN

lead

PepTonic Medical AB

INDUSTRY

NCT04489290 - Efficacy and Safety of D005 Vaginal Mousse on Bacterial Vaginosis | Biotech Hunter | Biotech Hunter